Logotype for The Clorox Company

The Clorox Company (CLX) Q2 2025 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for The Clorox Company

Q2 2025 earnings summary

9 Jan, 2026

Executive summary

  • Leadership transition announced: Kevin Jacobsen retiring as CFO, Luc Bellet to assume the role April 1st, ensuring continuity in financial strategy and transformation initiatives.

  • Q2 FY2025 net sales declined 15% to $1.69B, reflecting lapping of post-cyberattack recovery and divestitures; organic sales down 9%.

  • Diluted EPS rose 105% to $1.54, driven by lapping prior-year charges and cyberattack insurance recoveries; adjusted EPS fell 28% to $1.55.

  • Company has navigated significant disruptions in recent years, including pandemic-driven demand, inflation, and a cyber attack, while maintaining strong compounded annual sales growth and rebuilding gross margin.

  • Clorox and P&G will end the Glad joint venture in Jan 2026; Clorox to acquire P&G's 20% stake at fair market value.

Financial highlights

  • Q2 organic sales declined 9.5% year-over-year, outperforming guidance due to stronger category performance and share gains; Kingsford shipment timing contributed less than one point to the quarter.

  • Gross margin expanded 30 bps to 43.8%, supported by cost savings and divestitures, partially offset by higher costs.

  • Q2 net earnings: $194M, up from $96M a year ago; adjusted EBIT for Q2 was $258M, down 33% year-over-year.

  • Free cash flow is expected to land at the low end of the 11%-13% target range due to ERP-related inventory build, but operationally is closer to 13%.

  • Net cash from operations for six months: $401M, up 132%.

Outlook and guidance

  • FY2025 net sales expected to be down 1% to up 2%, including 1–2 pts benefit from ERP transition shipments.

  • Organic sales expected up 4–7%, excluding negative impacts from Argentina and VMS divestitures.

  • Gross margin now expected to rise 125–150 bps for FY2025.

  • FY2025 diluted EPS forecast raised to $5.52–$5.92 (up 145–163% YoY); adjusted EPS to $6.95–$7.35 (up 13–19%).

  • Long-term algorithm of 3%-5% annual growth reaffirmed, contingent on macro environment improvement and category normalization.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more